Halozyme Therapeutics Inc (NAS:HALO)
$ 74.96 +2.32 (+3.19%) Market Cap: 8.89 Bil Enterprise Value: 10.72 Bil PE Ratio: 26.96 PB Ratio: 40.45 GF Score: 92/100

Halozyme Therapeutics Inc (HALO) Transcripts

  • 1